162 related articles for article (PubMed ID: 23938462)
1. IL-18 regulates melanoma VLA-4 integrin activation through a Hierarchized sequence of inflammatory factors.
Valcárcel M; Carrascal T; Crende O; Vidal-Vanaclocha F
J Invest Dermatol; 2014 Feb; 134(2):470-480. PubMed ID: 23938462
[TBL] [Abstract][Full Text] [Related]
2. Metastatic lesions with and without interleukin-18-dependent genes in advanced-stage melanoma patients.
Crende O; Sabatino M; Valcárcel M; Carrascal T; Riestra P; López-Guerrero JA; Nagore E; Mandruzzato S; Wang E; Marincola FM; Vidal-Vanaclocha F
Am J Pathol; 2013 Jul; 183(1):69-82. PubMed ID: 23707237
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor regulates melanoma cell adhesion and growth in the bone marrow microenvironment via tumor cyclooxygenase-2.
Valcárcel M; Mendoza L; Hernández JJ; Carrascal T; Salado C; Crende O; Vidal-Vanaclocha F
J Transl Med; 2011 Aug; 9():142. PubMed ID: 21867538
[TBL] [Abstract][Full Text] [Related]
4. Sinusoidal endothelium release of hydrogen peroxide enhances very late antigen-4-mediated melanoma cell adherence and tumor cytotoxicity during interleukin-1 promotion of hepatic melanoma metastasis in mice.
Anasagasti MJ; Alvarez A; Martin JJ; Mendoza L; Vidal-Vanaclocha F
Hepatology; 1997 Apr; 25(4):840-6. PubMed ID: 9096586
[TBL] [Abstract][Full Text] [Related]
5. Resveratrol prevents inflammation-dependent hepatic melanoma metastasis by inhibiting the secretion and effects of interleukin-18.
Salado C; Olaso E; Gallot N; Valcarcel M; Egilegor E; Mendoza L; Vidal-Vanaclocha F
J Transl Med; 2011 May; 9():59. PubMed ID: 21569399
[TBL] [Abstract][Full Text] [Related]
6. Hydrogen peroxide mediates vascular cell adhesion molecule-1 expression from interleukin-18-activated hepatic sinusoidal endothelium: implications for circulating cancer cell arrest in the murine liver.
Mendoza L; Carrascal T; De Luca M; Fuentes AM; Salado C; Blanco J; Vidal-Vanaclocha F
Hepatology; 2001 Aug; 34(2):298-310. PubMed ID: 11481615
[TBL] [Abstract][Full Text] [Related]
7. Involvement of the very late antigen 4 integrin on melanoma in interleukin 1-augmented experimental metastases.
Garofalo A; Chirivi RG; Foglieni C; Pigott R; Mortarini R; Martin-Padura I; Anichini A; Gearing AJ; Sanchez-Madrid F; Dejana E
Cancer Res; 1995 Jan; 55(2):414-9. PubMed ID: 7529137
[TBL] [Abstract][Full Text] [Related]
8. Endothelial expression of vascular cell adhesion molecule-1 correlates with metastatic pattern in spontaneous melanoma.
Langley RR; Carlisle R; Ma L; Specian RD; Gerritsen ME; Granger DN
Microcirculation; 2001 Oct; 8(5):335-45. PubMed ID: 11687945
[TBL] [Abstract][Full Text] [Related]
9. High affinity interaction of integrin alpha4beta1 (VLA-4) and vascular cell adhesion molecule 1 (VCAM-1) enhances migration of human melanoma cells across activated endothelial cell layers.
Klemke M; Weschenfelder T; Konstandin MH; Samstag Y
J Cell Physiol; 2007 Aug; 212(2):368-74. PubMed ID: 17352405
[TBL] [Abstract][Full Text] [Related]
10. UVB-irradiation regulates VLA-4-mediated melanoma cell adhesion to endothelial VCAM-1 under flow conditions.
Wang L; Shirure VS; Burdick MM; Wu S
Mol Carcinog; 2011 Jan; 50(1):58-65. PubMed ID: 21061269
[TBL] [Abstract][Full Text] [Related]
11. Melanoma cell adhesion can be blocked by heparin in vitro: suggestion of VLA-4 as a novel target for antimetastatic approaches.
Fritzsche J; Simonis D; Bendas G
Thromb Haemost; 2008 Dec; 100(6):1166-75. PubMed ID: 19132244
[TBL] [Abstract][Full Text] [Related]
12. NK cell infiltration into lung, liver, and subcutaneous B16 melanoma is mediated by VCAM-1/VLA-4 interaction.
Fogler WE; Volker K; McCormick KL; Watanabe M; Ortaldo JR; Wiltrout RH
J Immunol; 1996 Jun; 156(12):4707-14. PubMed ID: 8648116
[TBL] [Abstract][Full Text] [Related]
13. Vascular cell adhesion molecule 1 (CD106) on primary human articular chondrocytes: functional regulation of expression by cytokines and comparison with intercellular adhesion molecule 1 (CD54) and very late activation antigen 2.
Kienzle G; von Kempis J
Arthritis Rheum; 1998 Jul; 41(7):1296-305. PubMed ID: 9663488
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide/cGMP pathway signaling actively down-regulates α4β1-integrin affinity: an unexpected mechanism for inducing cell de-adhesion.
Chigaev A; Smagley Y; Sklar LA
BMC Immunol; 2011 May; 12():28. PubMed ID: 21586157
[TBL] [Abstract][Full Text] [Related]
15. In vitro VLA-4 blockade results in an impaired NK cell-mediated immune surveillance against melanoma.
Gandoglia I; Ivaldi F; Carrega P; Armentani E; Ferlazzo G; Mancardi G; Kerlero de Rosbo N; Uccelli A; Laroni A
Immunol Lett; 2017 Jan; 181():109-115. PubMed ID: 27919749
[TBL] [Abstract][Full Text] [Related]
16. CD47 plays a critical role in T-cell recruitment by regulation of LFA-1 and VLA-4 integrin adhesive functions.
Azcutia V; Routledge M; Williams MR; Newton G; Frazier WA; Manica A; Croce KJ; Parkos CA; Schmider AB; Turman MV; Soberman RJ; Luscinskas FW
Mol Biol Cell; 2013 Nov; 24(21):3358-68. PubMed ID: 24006483
[TBL] [Abstract][Full Text] [Related]
17. IL-4 inhibits VLA-4 expression on Tc1 cells resulting in poor tumor infiltration and reduced therapy benefit.
Sasaki K; Pardee AD; Okada H; Storkus WJ
Eur J Immunol; 2008 Oct; 38(10):2865-73. PubMed ID: 18958887
[TBL] [Abstract][Full Text] [Related]
18. Involvement of very late activation antigen 4 (VLA-4) and vascular cell adhesion molecule 1 (VCAM-1) in tumor necrosis factor alpha enhancement of experimental metastasis.
Okahara H; Yagita H; Miyake K; Okumura K
Cancer Res; 1994 Jun; 54(12):3233-6. PubMed ID: 7515767
[TBL] [Abstract][Full Text] [Related]
19. CXCR4 and vascular cell adhesion molecule 1 are key chemokine/adhesion receptors in the migration of cytokine-activated T cells.
Bryant J; Ahern DJ; Brennan FM
Arthritis Rheum; 2012 Jul; 64(7):2137-46. PubMed ID: 22275188
[TBL] [Abstract][Full Text] [Related]
20. Galphas-coupled receptor signaling actively down-regulates alpha4beta1-integrin affinity: a possible mechanism for cell de-adhesion.
Chigaev A; Waller A; Amit O; Sklar LA
BMC Immunol; 2008 Jun; 9():26. PubMed ID: 18534032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
